| Matthew Faiman, MD | |
|
914 N Scottsdale Rd Ste 104, Tempe, AZ 85288-2116 | |
| (480) 924-8382 | |
| Not Available |
| Full Name | Matthew Faiman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 914 N Scottsdale Rd Ste 104, Tempe, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184730806 | NPI | - | NPPES |
| 2334843 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 35081211F (Ohio) | Primary |
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
Could engineered human stem cells hold the key to cancer survival? Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have discovered that neural stem cells possess the innate ability to target tumor cells outside the central nervous system. This finding, which was demonstrated successfully on breast cancer cells, was recently published in leading peer reviewed journal, Stem Cells.
"High levels of unmet need for contraception around the world have a very negative impact on women's and children's health and survival as well as on the prosperity of communities and nations," Rep. Carolyn Maloney (D-N.Y.) writes in the Huffington Post's "Global Motherhood" blog.
The decision on Tuesday by Japan's Nuclear and Industrial Safety Agency to increase the level of severity at the Fukushima Daiichi nuclear power plant "does not mean the public health risk is any worse or that the disaster resembles Chernobyl in 1986," the WHO and other agencies said in response to the announcement, Reuters reports.
Young mothers have a greater chance of having a child with attention deficit hyperactivity disorder according to new research from the University of South Australia.
The Medtronic Inc. has won the CE Mark approval for a peripheral nerve stimulation device for treating chronic back pain. This medical device maker from Minneapolis, Minn. said the implantable device will fit into its neurostimulation business, which operates out of the company's restorative therapies division. That unit was responsible for about $5.42 billion in sales during the nine-month period ended Jan. 28.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Faiman, MD 6000 W Creek Rd, Suite 10, Independence, OH 44131-2139 Ph: (800) 223-2273 | Matthew Faiman, MD 914 N Scottsdale Rd Ste 104, Tempe, AZ 85288-2116 Ph: (480) 924-8382 |
News Archive
Could engineered human stem cells hold the key to cancer survival? Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have discovered that neural stem cells possess the innate ability to target tumor cells outside the central nervous system. This finding, which was demonstrated successfully on breast cancer cells, was recently published in leading peer reviewed journal, Stem Cells.
"High levels of unmet need for contraception around the world have a very negative impact on women's and children's health and survival as well as on the prosperity of communities and nations," Rep. Carolyn Maloney (D-N.Y.) writes in the Huffington Post's "Global Motherhood" blog.
The decision on Tuesday by Japan's Nuclear and Industrial Safety Agency to increase the level of severity at the Fukushima Daiichi nuclear power plant "does not mean the public health risk is any worse or that the disaster resembles Chernobyl in 1986," the WHO and other agencies said in response to the announcement, Reuters reports.
Young mothers have a greater chance of having a child with attention deficit hyperactivity disorder according to new research from the University of South Australia.
The Medtronic Inc. has won the CE Mark approval for a peripheral nerve stimulation device for treating chronic back pain. This medical device maker from Minneapolis, Minn. said the implantable device will fit into its neurostimulation business, which operates out of the company's restorative therapies division. That unit was responsible for about $5.42 billion in sales during the nine-month period ended Jan. 28.
› Verified 9 days ago
Dr. Steven Alex Baldwin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1898 E Southern Ave, Tempe, AZ 85282 Phone: 480-838-0068 Fax: 480-838-3409 | |
Denise I Beighe, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 451 E University Dr, Tempe, AZ 85281 Phone: 480-965-3346 Fax: 480-965-8914 | |
Dr. M. Jamil Akhtar, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2157 E Baseline Rd, Suite 101, Tempe, AZ 85283 Phone: 480-962-9494 Fax: 480-962-8140 | |
Emil Slovak Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4600 S Mill Ave, Suite 280, Tempe, AZ 85282 Phone: 480-305-2888 Fax: 480-305-2889 | |
Supriya Bhandari, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 E Broadway Rd, Tempe, AZ 85282 Phone: 602-243-7277 Fax: 480-927-1092 | |
Dr. Monaliza Setudehnia, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2055 E Southern Ave, Suite D, Tempe, AZ 85282 Phone: 480-345-7676 | |
Bhupinder Singh, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2141 E Warner Rd, Suite 101, Tempe, AZ 85284 Phone: 480-969-8714 Fax: 480-464-0189 |